BAM
RNTX

Brave Asset Management’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Brave Asset Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-833
Closed -$32K – 166
2019
Q1 		$32K Sell
833
-300
-26% -$11.5K 0.02% 141
2018
Q4 		$19K Buy
1,133
+383
+51% +$6.42K 0.01% 136
2018
Q3 		$41K Buy
+750
New +$41K 0.02% 141